Osaic Holdings’s Cyclerion Therapeutics CYCN Stock Holding History

Osaic Holdings’s Portfolio CYCN Stock Details CYCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$440	Hold	130	–	–	﹤0.01%	7674
2026 Q1	$201	Hold	130	–	–	﹤0.01%	7560
2025 Q4	$165	Hold	130	–	–	﹤0.01%	7597
2025 Q3	$304	Hold	130	–	–	﹤0.01%	7636
2025 Q2	$378	Hold	130	–	–	﹤0.01%	7395
2025 Q1	$325	Hold	130	–	–	﹤0.01%	7086
2024 Q4	$418	Buy	+130	New	+$362	﹤0.01%	7056
2024 Q1	–	Sell	-187	Closed	-$626	–	7233
2023 Q4	$626	Sell	187 -1	-0.5%	-$3	﹤0.01%	6859
2023 Q3	$643	Buy	+188	New	+$678	﹤0.01%	6939
2022 Q2	–	Sell	-1	Closed	–	–	7388
2022 Q1	$0	Hold	1	–	–	﹤0.01%	7288
2021 Q4	$0	Hold	1	–	–	﹤0.01%	7412
2021 Q3	$0	Buy	+1	New	+$65	﹤0.01%	7206

Other funds holding CYCN

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Osaic Holdings's CYCN Position: Q2 2026 in Review

Osaic Holdings held its Cyclerion Therapeutics (CYCN) position steady in Q2 2026 at 130 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #7674.

Osaic Holdings first reported a position in CYCN in Q3 2021 and has held it in 12 quarters since. The position peaked at $643 in Q3 2023. 21 funds tracked by Wall St. Rank hold CYCN as of Q2 2026.

Osaic Holdings held 130 shares of Cyclerion Therapeutics worth $440 as of Q2 2026.
Osaic Holdings left its Cyclerion Therapeutics share count unchanged in Q2 2026.
Cyclerion Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7674 holding.
Osaic Holdings first reported a position in Cyclerion Therapeutics in Q3 2021 and has held it in 12 quarters since.
Osaic Holdings's Cyclerion Therapeutics position peaked at $643 in Q3 2023.
21 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.